NCT01562938View on ClinicalTrials.gov

MEDI-557 Adult Dosing

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

July 31, 2013

Conditions

Respiratory Syncytial Virus

Interventions

DRUG

Placebo

Placebo

DRUG

MEDI-557

MEDI-557 low-dose

DRUG

MEDI-557

MEDI-557 high-dose

Trial Locations (1)

Unknown

Research Site, Miami

Sponsors

Lead Sponsor

All Listed Sponsors

lead

MedImmune LLC

INDUSTRY

NCT01562938 - MEDI-557 Adult Dosing | Biotech Hunter | Biotech Hunter